Compare NNNN & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | SMHI |
|---|---|---|
| Founded | 2021 | 1989 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.4M | 267.5M |
| IPO Year | 2023 | 2016 |
| Metric | NNNN | SMHI |
|---|---|---|
| Price | $4.90 | $8.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 199.7K | 82.0K |
| Earning Date | 10-23-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.41 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $173,783,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.02 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.66 | $5.55 |
| 52 Week High | $44.73 | $10.00 |
| Indicator | NNNN | SMHI |
|---|---|---|
| Relative Strength Index (RSI) | 28.21 | 38.36 |
| Support Level | N/A | $7.01 |
| Resistance Level | $6.95 | $10.00 |
| Average True Range (ATR) | 0.55 | 0.35 |
| MACD | 0.05 | -0.08 |
| Stochastic Oscillator | 7.01 | 27.30 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.